Brazil Peripheral Vascular Devices Market Insight
Brazil Peripheral Vascular Devices Market is growing due to rising prevalence of peripheral artery diseases, increasing demand for minimally invasive vascular procedures, and growing adoption of advanced endovascular treatment technologies across hospitals, cardiac care centers, and specialty vascular clinics at 9.22% CAGR
Brazil Peripheral Vascular Devices Market Insights Forecasts to 2035
- The Brazil Peripheral Vascular Devices Market Size Was Estimated at USD 173.7 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around
9.22% from 2025 to 2035 - The Brazil Peripheral Vascular Devices Market Size is Expected to Reach USD 71.91 Million by 2035
Notable Insights for Brazil Peripheral Vascular Devices Market
- By product type, Angioplasty Balloons segment is dominating accounting over approx. 34% in the Brazil Peripheral Vascular Devices Market in 2025.
- By end-use industry, Hospitals & Critical Care Centers segment is the dominating accounting for approximately 46.1% of the Brazil Peripheral Vascular Devices Market share in 2025.
- Rising investments in cardiovascular treatment infrastructure, catheterization laboratories, vascular intervention centers, and minimally invasive surgical technologies accelerated deployment of advanced peripheral vascular devices by 35–43%.
- Healthcare providers experienced a 37–48% increase in adoption of drug-coated balloons, AI-assisted vascular imaging systems, and smart catheter-based intervention technologies
Download the eBook (ToC)
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the Brazil Peripheral Vascular Devices Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in Brazil Peripheral Vascular Devices Market
- Medtronic plc
- Boston Scientific Corporation
- Abbott Laboratories
- Terumo Corporation
- Cook Medical
- BD (Becton, Dickinson and Company)
- Cardinal Health
- Biotronik SE & Co. KG
- Braile Biomedica
- AngioDynamics Inc.
- Merit Medical Systems
- Teleflex Incorporated
Recent Developments:
- In January 2026, Boston Scientific and Penumbra Boston Scientific announced an agreement to acquire Penumbra to strengthen its peripheral and neurovascular portfolio with advanced thrombectomy and clot-removal technologies.
- In August 2025, Abbott Laboratories Dissolving Stents received approvals for next-generation dissolvable stents designed for peripheral vascular treatment and improved vascular healing outcomes.
Market Segmentation:
Brazil Peripheral Vascular Devices Market, By Product Type
- Angioplasty Balloons
- Catheters
- Peripheral Stents
- Guidewires
- Atherectomy Devices
- Vena Cava Filters
Brazil Peripheral Vascular Devices Market, By End-Use Industry
- Hospitals & Cardiac Care Centers
- Ambulatory Surgical Centers
- Specialty Vascular Clinics
- Catheterization Laboratories
- Research & Academic Institutes
- Home Healthcare
Brazil Peripheral Vascular Devices Market, By Technology
- Conventional Endovascular Devices
- Drug-Coated Vascular Devices
- AI-Integrated Vascular Imaging Platforms
- Real-Time Smart Catheter Navigation Systems
Expert Views:
The Brazil Peripheral Vascular Devices Market will experience strong growth because of increasing prevalence of peripheral artery diseases and rising demand for minimally invasive vascular procedures and growing investments in cardiovascular healthcare infrastructure. The market will develop AI-enabled and IoT-connected vascular intervention ecosystems which hospitals and specialty cardiac care centers will use because of technological advancements in drug-coated vascular devices and real-time vascular imaging systems and smart catheter navigation technologies and advanced minimally invasive treatment solutions.